Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Anadys Pharmaceuticals | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Anadys Pharmaceuticals

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Carol G. Gallagher, Pharm. D., has been named vice president, commercial affairs, at Anadys Pharmaceuticals. Dr. Gallagher will be responsible for commercial affairs, including business development, market planning and strategic planning. “We are very pleased that Carol is joining Anadys,” said Kleanthis G. Xanthopoulos, Ph.D., Anadys’ president and chief executive officer. “Her leadership and experience in managing many therapeutic agents with multiple partners on a worldwide basis will be critical to Anadys as we build the foundation of our commercialization strategy.”

Prior to joining Anadys, Dr. Gallagher was the vice president, sales, marketing and product planning at CancerVax Corp. Previously, she was senior director of oncology marketing at Biogen Idec. During that time, her role included leadership of the Rituxan collaboration with Genentech. She also worked as director, global marketing planning for oncology and ophthalmology at Pfizer, and held other marketing positions, including product and new product management roles, at Agouron Pharmaceuticals, Lilly and Amgen.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters